Two Sigma Investments’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.23M | Buy |
+1,725,360
| New | +$4.23M | 0.01% | 1300 |
|
|
2025
Q1 | – | Sell |
-41,142
| Closed | -$517K | – | 3380 |
|
|
2024
Q4 | $517K | Buy |
41,142
+19,326
| +89% | +$243K | ﹤0.01% | 2464 |
|
|
2024
Q3 | $403K | Sell |
21,816
-1,275
| -6% | -$23.5K | ﹤0.01% | 2493 |
|
|
2024
Q2 | $497K | Sell |
23,091
-126,917
| -85% | -$2.73M | ﹤0.01% | 2299 |
|
|
2024
Q1 | $4.04M | Sell |
150,008
-104,908
| -41% | -$2.83M | 0.01% | 1043 |
|
|
2023
Q4 | $7.64M | Sell |
254,916
-141,423
| -36% | -$4.24M | 0.02% | 737 |
|
|
2023
Q3 | $8.12M | Buy |
396,339
+352,239
| +799% | +$7.22M | 0.02% | 640 |
|
|
2023
Q2 | $876K | Sell |
44,100
-102,179
| -70% | -$2.03M | ﹤0.01% | 1942 |
|
|
2023
Q1 | $2.51M | Buy |
146,279
+74,329
| +103% | +$1.27M | 0.01% | 1190 |
|
|
2022
Q4 | $1.41M | Sell |
71,950
-267,049
| -79% | -$5.23M | ﹤0.01% | 1466 |
|
|
2022
Q3 | $5.41M | Buy |
338,999
+120,037
| +55% | +$1.92M | 0.02% | 702 |
|
|
2022
Q2 | $3.01M | Sell |
218,962
-25,688
| -10% | -$353K | 0.01% | 941 |
|
|
2022
Q1 | $3.88M | Sell |
244,650
-3,464
| -1% | -$54.9K | 0.01% | 1009 |
|
|
2021
Q4 | $5.42M | Buy |
248,114
+40,239
| +19% | +$878K | 0.01% | 882 |
|
|
2021
Q3 | $6.21M | Buy |
207,875
+39,306
| +23% | +$1.17M | 0.01% | 798 |
|
|
2021
Q2 | $7.47M | Sell |
168,569
-162,717
| -49% | -$7.21M | 0.02% | 760 |
|
|
2021
Q1 | $14.7M | Buy |
331,286
+227,806
| +220% | +$10.1M | 0.04% | 462 |
|
|
2020
Q4 | $5.68M | Buy |
103,480
+88,973
| +613% | +$4.88M | 0.02% | 686 |
|
|
2020
Q3 | $332K | Sell |
14,507
-8,479
| -37% | -$194K | ﹤0.01% | 1549 |
|
|
2020
Q2 | $481K | Buy |
+22,986
| New | +$481K | ﹤0.01% | 1439 |
|
|
2015
Q4 | – | Sell |
-8,798
| Closed | -$331K | – | 2238 |
|
|
2015
Q3 | $331K | Buy |
+8,798
| New | +$331K | ﹤0.01% | 1358 |
|